A clinicopathologic study of 108 cases of high-grade urothelial carcinomas of the renal pelvis is presented. Of the 108 tumors, 44 (40%) showed unusual morphologic features, including micropapillary areas (four cases), lymphoepithelioma-like carcinoma (two cases), sarcomatoid carcinoma (eight cases, including pseudoangiosarcomatous type), squamous differentiation and squamous cell carcinoma (15 cases), clear cells (two cases), glandular differentiation (two cases), rhabdoid, signet-ring or plasmacytoid cells (four cases), pseudosarcomatous stromal changes (four cases) and intratubular extension into the renal pelvis (three cases). Pathological staging was available in 62 patients; of these, 46 cases (74%) were in high stage (pT2-pT4) and 16 (26%) were in low stage (pTis, pTa, pT1). Clinical follow-up ranging from 1 to 256 months (median: 50 months) was available in 42 patients; of these, 26 (61%) died of tumor with a median survival of 31 months. The patients who did not die of their tumors showed only minimal or focal infiltration of the renal parenchyma by urothelial carcinoma, whereas those who died of their tumors showed massive infiltration of the kidney by the tumor. High-grade urothelial carcinomas of the renal pelvis can show a broad spectrum of histologic features similar to those seen in the urinary bladder. Our results support the finding that, unlike urothelial carcinomas of the bladder, the majority of primary urothelial carcinomas of the renal pelvis are of high histologic grade and present in advanced stages. Our study further highlights the fact that, in the renal pelvis, urothelial carcinomas show a tendency to frequently display unusual morphologic features and metaplastic phenomena. The importance of recognizing these morphologic variants of urothelial carcinoma in the renal pelvis is to avoid confusion with other conditions. The possibility of a high-grade urothelial carcinoma should always be considered in the evaluation of a tumor displaying unusual morphologic features in the renal pelvis, and attention to proper sampling as well as the use of immunohistochemical stains will be of importance to arrive at the correct diagnosis. Urothelium can display a wide range of metaplastic changes, and neoplasms arising from this epithelium can show several types of differentiation, especially in high-grade neoplasms. These changes have been described in detail in the urinary bladder, 2-4 but have not been thoroughly analyzed in the renal pelvis. Their location within the kidney and the unusual morphologic appearances of these tumors may pose a challenge for histopathologic diagnosis.
Primary neoplasms of the renal pelvis are rare and account for approximately 7% of all renal tumors; 1 the majority of them are of transitional cell type. Urothelium can display a wide range of metaplastic changes, and neoplasms arising from this epithelium can show several types of differentiation, especially in high-grade neoplasms. These changes have been described in detail in the urinary bladder, 2-4 but have not been thoroughly analyzed in the renal pelvis. Their location within the kidney and the unusual morphologic appearances of these tumors may pose a challenge for histopathologic diagnosis.
The purpose of this study is to report the clinicopathologic features in a series of high-grade urothelial carcinomas of the renal pelvis with emphasis on unusual morphologic variants of these tumors.
Materials and methods
All cases of total nephrectomy specimens coded as carcinoma of the renal pelvis were retrieved from the surgical pathology files at the Ohio State University Medical Center between the years 1970 and 2000, and from the University Hospital in Plzen, the Czech Republic between 1995 and 2001. Demographic features analyzed included age, sex, tumor location and clinical stage. A total of 157 patients were identified. Of the 157 cases, 108 (69%) were classified as high-grade neoplasms according to the WHO/ISUP consensus. 5 From six to 14 glass slides stained with hematoxylin & eosin were retrieved for each case. The histologic features analyzed included: growth pattern, histologic type, histologic grade, evidence of divergent differentiation, unusual stromal features and patterns of infiltration into the adjacent renal parenchyma. Pathological staging was established using the current American Joint Committee on Cancer (AJCC/TNM) system. 6 A few of the patients included in this series are presented in more detail elsewhere. 7 Selected tumors in which morphologic features could give rise to alternate diagnoses were stained with a panel of immunohistochemical markers and with histochemical stains including the periodic acidSchiff (PAS) reaction and Alcian blue. DNAin situ hybridization for Epstein-Barr virus (EBV) (EBER) was performed in the two cases of lymphoepithelioma-like carcinoma (LELC). For immunohistochemical analysis, formalin-fixed, paraffin-embedded tissue sections were cut at 4 mm, dried for 1 h at 601C, deparaffinized in xylene and rehydrated through graded alcohols. Antigen retrieval was performed using Target Retrieval Solution, 10 Â concentrate (DakoCytomation, Carpinteria, CA, USA) for all the antibodies tested, except for actin. Endogenous peroxidase activity was quenched by immersion in absolute methanol containing 3% (vol/vol) hydrogen peroxide for 5 min. Immunohistochemical stains were performed with commercially available antibodies utilizing a standard avidin-biotin complex immunoperoxidase technique in a Dako Autostainer (Dako). Tissue sections were incubated with antibodies to cytokeratin AE1/ AE3 (DakoCytomation; 1:1000), CK7 (DakoCytomation; 1:200), CK20 (DakoCytomation; 1:200), polyclonal CEA (DakoCytomation; 1:1000), vimentin (DakoCytomation; 1:200), EBV LMP (CS 1-4) (DakoCytomation; 1:200), EMA (DakoCytomation; 1:400) and CD10 (Novocastra, Newcastle, UK; 1:20). Positive and negative controls were run concurrently for all antibodies tested.
For EBER-1 and EBER-2 detection, RNA-in situ hybridization was performed on sections using fluorescein-tagged oligomers specific for EBER-1 and EBER-2, according to the manufacturer's recommendations (Ventana Medical Systems, Tucson, AZ, USA). This system employs nitroblue tetrazolium and bromochloroindoly phosphate as the chromogen and nuclear fast red as nuclear counterstain; thus, a positive signal was evident as a dark blue color against a light pink background.
Results

Clinical Features
The ages of our patients ranged from 40 to 106 years with a median of 67 years. In all, 39 patients were women, and 62 patients were men; in seven cases, the patient's gender could not be established due to incomplete clinical information. In total, 44 tumors were located on the left side, 36 on the right side, one was bilateral and in 27 cases information regarding laterality was not available. Clinical staging information was not available in all patients because of the referral nature of many of the cases. Staging information was available in 62 patients with high-grade carcinoma: 16 patients were in low pathological stage (a-1) and 46 were in high pathological stage (2-4) ( Table 1) . Clinical followup ranging from 1 to 256 months (median 50 months) was available in 42 patients; 26 died with tumor with a median survival of 31 months; of these, 24 were in high stage and two were in low stage. Five patients died of unrelated causes and 11 patients were alive with no evidence of tumor (three with high stage and eight with low stage). The three patients with high-stage tumors who are alive showed only focal infiltration of the kidney by tumor. In contrast, patients in the same stage and grade who died of their tumors showed extensive invasion of the kidney by tumor. Seven patients also had a synchronous intraparenchymatous renal tumor, of which four were conventional clear cell renal cell carcinomas, one was a papillary renal cell carcinoma, and two were incidental metanephric adenomas.
Pathologic Features
The majority of the tumors (60%) showed the conventional features of high-grade urothelial carcinoma according to previously established criteria. 5 In all, 44 cases in this study (40%) showed unusual morphologic features (Table 2) . High-grade urothelial carcinoma with conventional features (CHGUC) These tumors showed an abnormal architecture, in which the cells appeared predominantly or totally disorderly on scanning magnification, and showed a variable degree of nuclear atypia ranging from moderate to severe with pleomorphic features (Figure 1 ). The majority of the tumors were papillary, but solid and diffuse patterns were also recognized. positive for vimentin and actin, and negative for all epithelial markers. Both components were negative for CD31 and CEA.
Micropapillary carcinoma
Urothelial carcinoma with squamous differentiation
In all, 14 patients with CHGUC showed tumors with prominent areas of squamous differentiation characterized by sheets of cells with well-defined cell borders, deeply eosinophilic cytoplasm, focal keratin pearl formation and large nuclei with prominent nucleoli occupying more than 30% of the tumor. All these tumors showed areas of transition with urothelial carcinoma and had infiltrating borders with wide invasion of the renal parenchyma. One case showed a pure high-grade squamous cell carcinoma (SCC) associated with squamous metaplasia of the urothelium in the renal pelvis. CHGUC with spread into the renal pelvis Most tumors in the present series had a pushing or infiltrative border, but in three patients, an unusual form of intratubular spread was present. In these tumors, the neoplastic transitional epithelium lined, and in some cases filled, the lumen of the minor calyces and collecting tubules (Figure 8 ). In one case, replacement of the normal epithelium by dysplastic urothelium in a Pagetoid pattern was seen. The neoplastic cells were confined to the tubules without infiltration into the surrounding renal parenchyma, similar to the process of cancerization of ducts or lobules sometimes observed in the breast of patients with mammary carcinoma.
Clear cell change
Discussion
Urothelial carcinomas of the renal pelvis are relatively rare tumors that account for approxi- Urothelial carcinoma of renal pelvis D Perez-Montiel et al mately 7% of all renal neoplasms. 1 Interestingly, the majority of urothelial carcinomas arising from the renal pelvis are high-grade tumors. We have analyzed a series of primary high-grade urothelial carcinomas of the renal pelvis. These tumors accounted for 69% of all urothelial carcinomas of the renal pelvis in our material. In a recent study by Olgac et al, 8 71% of all urothelial carcinomas of the renal pelvis were high grade. Another recent study also showed that 89% of urothelial carcinomas of the renal pelvis were either grade 2/3 or 3/3. 9 Urothelial carcinomas of the renal pelvis also more often appear to be in higher stages than their urinary bladder counterpart. In the study by Olgac et al, 45% of the tumors presented in high pathological stages, compared with bladder tumors, of which only 25% were in high stages. 8 In the present series, staging information was available in 62 patients with high-grade carcinomas and 74% of our cases (46/62 cases) were high stage.
Morphologic variation due to aberrant differentiation is a well-recognized phenomenon in urothelial carcinoma of the bladder. 2 The most commonly reported events are squamous and glandular differentiation, which may be focal or widely distributed. 4 The same phenomenon may involve other sites along the urogenital tract. In the renal pelvis, unusual variants of urothelial carcinoma displaying divergent differentiation have also been rarely described. 2, 3 The majority of the tumors in our study (60%) showed the usual features of high-grade transitional cell carcinoma. However, 40% of the cases in this series were characterized by unusual morphologic features, including a micropapillary component, undifferentiated (lymphoepitheliomalike) areas, spindle cell (sarcomatoid) morphology, squamous differentiation and glandular differentiation with mucus-producing cells. In addition, tumors with clear cells, signet-ring cells, rhabdoid cells and plasmacytoid cells were also seen. A reactive spindle cell pseudosarcomatous stroma was also present in some cases, as well as an unusual form of spread into renal tubules. The occurrence of these unusual morphologic features may contribute to difficulties in the histopathologic diagnosis of these lesions.
The micropapillary variant of urothelial carcinoma is a very rare form of urothelial carcinoma that has been reported in the urinary bladder, 10 ureter 7, 11 and renal pelvis. 7, 12 Two different patterns have been described in the urinary tract, the invasive micropapillary pattern composed of tight clusters of neoplastic atypical cells that form small micropapillary structures surrounded by clear retraction spaces and the noninvasive pattern composed of slender finger-like projections with or without fibrovascular cores. 10 The main differential diagnosis for these tumors is with metastasis of papillary carcinoma from other organs or with the papillary variant of renal cell carcinoma; thorough sampling with identification of areas showing the more classical features of urothelial carcinoma may be helpful for establishing a definitive diagnosis.
'Lymphoepithelioma' is the old term used to designate a poorly differentiated malignant epithelial tumor of the nasopharynx related in most cases to EBV. LELC has been reported in other organs such as salivary glands, 13 lung, 14 thymus, 15 cervix, 16 skin, 17 stomach 18 urinary bladder 19, 20 and renal pelvis. 21, 22 In the single case reported of LELC of the renal pelvis studied for EBV by in situ hybridization, 22 the Epstein-Barr viral genome was negative. In the present study, both the anti-EBV LMP antibody as well as the EVB-EBER by DNAin situ hybridization was also negative in both tumors tested. The main differential diagnosis for these tumors is with high-grade lymphoma; immunoreactivity for cytokeratin in the atypical cell component will help establish the correct diagnosis.
Eight tumors in our series were classified as sarcomatoid carcinoma of the renal pelvis. This tumor has been previously well recognized in the renal pelvis. [23] [24] [25] All of the tumors in the present series had recognizable areas of high-grade TCC in addition to the sarcomatoid areas. Sarcomatoid urothelial carcinoma of the urinary tract has been reported in advanced stages at the time of diagnosis and is associated with a poor prognosis. 24, 25 Clinical follow-up was available only in two cases in our study: one patient died 3 months after diagnosis with metastasis from a pT3 tumor, and the other patient who had a pT2 tumor was alive and free of disease 108 months after diagnosis. The differential diagnosis for these lesions includes a variety of spindle cell sarcomas and secondary infiltration of the renal pelvis by sarcomatoid renal cell carcinoma. Identification of better-differentiated areas of urothelial carcinoma as well as demonstration of transitions with in situ urothelial carcinoma can help in the differential diagnosis. Immunohistochemical studies are of limited value, since there can be much overlap between sarcomatoid carcinoma of the renal pelvis and sarcomatoid renal cell carcinoma in their reactivity for the different markers available.
SCCs have been reported in the renal pelvis and account for 10% of cases in some series. 26 They are usually associated with calculi, chronic infection and squamous metaplasia of the neighboring epithelium. 27, 28 The majority are keratinizing tumors that show high nuclear grade and have an unfavorable prognosis, but there are reported cases of verrucous carcinoma associated with urolithiasis that have a better clinical outcome. 29 Only one patient in our study corresponded to a pure SCC, with focal areas of squamous metaplasia of transitional epithelium. In all, 14 patients in our series, however, had high-grade urothelial carcinomas showing prominent areas of squamous differentiation, two of them displaying focal clear cell changes. These tumors showed infiltrating borders with extensive invasion of the renal parenchyma and they were in Urothelial carcinoma of renal pelvis D Perez-Montiel et al pathological stage T3, except for one case that was T2 and another one that was T4. Clear cell appearance has been reported as an infrequent change in urothelial tumors. 30 In the present series, this phenomenon was observed involving wide areas of the tumor in four high-grade urothelial carcinoma, two in association with areas of squamous or glandular differentiation. In the urinary bladder, the differential diagnosis for these tumors is with adenocarcinomas of Mullerian origin, or metastases from a clear cell renal cell carcinoma. 31 In the renal pelvis, the main differential diagnosis is with secondary invasion by a clear cell renal cell carcinoma. Some cases can be problematic, especially in high-grade tumors with pleomorphism and mitoses that show extensive clear cell changes. Identification of areas displaying features of conventional transitional cell carcinoma will be of help for arriving at the correct diagnosis. Immunohistochemical stains can also be of aid in distinguishing clear cell renal cell carcinoma from high-grade urothelial carcinoma with clear cell features. Urothelial carcinomas are negative for the renal cell carcinoma antigen and positive for CK7 and CK20, while renal cell carcinoma is generally negative for CK20 and positive for RCC antigen. 32, 33 Tumors with areas showing the features of 'rhabdoid' tumors have been described in highgrade urothelial carcinoma. 34 Microscopically, the cells show abundant cytoplasm with paranuclear eosinophilic inclusions corresponding to whorls of intermediate filaments as seen by electron microscopy. In the cases reported in the literature, the patients had a rapidly progressive clinical course. The only patient in our study showing this feature for which we had clinical follow-up also followed a rapidly fatal course. The differential diagnosis for these lesions is with rhabdoid tumors of the kidney; however, this tumor is generally a childhood neoplasm that only rarely occurs in adults. Another condition that may enter in the differential diagnosis is renal cell carcinoma. Renal cell carcinoma can also display a rhabdoid phenotype, usually in association with areas of conventional clear cell renal cell carcinoma. 35 The differential diagnosis can be clarified by demonstrating transitions with areas of better differentiated RCC, or by finding foci of in situ urothelial carcinoma with dysplasia of the urothelium.
Plasmacytoid urothelial carcinoma is a rare variant of urothelial neoplasm described in the urinary bladder in association with high-grade tumors. 36 One of the cases reported in the bladder had bone metastasis and was confused with a plasmacytoma. 37 Immunohistochemical stains may be of aid in such instances for distinguishing these tumors from lymphomas and other lymphoproliferative conditions by demonstrating light chain restriction and absence of markers of maturation of B-lymphocytes such as CD20. It is interesting to note in this context that none of the patients in our series showed features of small-cell neuroendocrine carcinoma. Small-cell neuroendocrine carcinoma has been reported in the urinary bladder as an uncommon tumor that affects predominantly older patients and is associated with a poor prognosis and several large series have been reported in the literature. 38, 39 However, only a few case reports have been published on this type of tumor arising in the renal pelvis. [40] [41] [42] The reason for this discrepancy is not apparent.
A peculiar pattern of intratubular infiltration of the renal papilla was seen in three cases. In these cases, the transitional neoplastic epithelium lined the minor calyces and replaced the normal epithelium. In one patient, the infiltration of the tubules displayed a pagetoid appearance. The gross appearance of this type of extension into the tubules can be quite deceptive and in some cases can mimic amyloid kidney. 43 This form of infiltration can be confused with primary carcinoma of the kidney such as carcinoma with tubular differentiation, ductal cell carcinoma or loopomas. 44 Another differential diagnosis for these tumors is the nested variant of urothelial carcinoma described in the bladder by Murphy and Deana. 45 This variant is characterized by neoplastic cells arranged in small nests and within small tubular lumina; the recognition of normal collecting tubules filled with cells and the presence of urothelial carcinoma in the renal pelvis are the most useful signs to rule out this lesion.
Pseudosarcomatous myofibroblastic reaction is a change that can be seen in urothelial carcinoma, although it is more commonly seen as a sequel to inflammatory processes or postoperatively following endoscopic procedures. 46 When associated with cancer, even the metastases from urothelial carcinoma can display this pseudosarcomatous reaction. 47 The histological features include an edematous or myxoid background with spindle cells showing large nuclei, often prominent nucleoli and scant normal-appearing mitotic figures, but no cytologic atypia. The differential diagnosis is with sarcomatoid carcinoma. Some tumors in our series with pseudosarcomatous stroma showed apparent transitions between the epithelial nests and the spindle cells; however, despite some nuclear enlargement, the chromatin was not coarse and stains for epithelial markers were negative in the stromal component.
In summary, high-grade urothelial carcinomas of the renal pelvis can have a broad spectrum of histologic features similar to those seen in the urinary bladder. Our results support the findings of Olgac et al 8 that, unlike urothelial carcinomas of the bladder, the majority of primary urothelial carcinomas of the renal pelvis are of high histologic grade and present in advanced stages. Our study also showed that the extent of infiltration into the adjacent renal parenchyma by high-grade urothelial carcinoma of the renal pelvis appears to show a direct correlation with clinical outcome; study of additional patients may help confirm this observation. This study additionally highlights the fact that, in the renal pelvis, urothelial carcinomas have a tendency to frequently display unusual morphologic features and metaplastic phenomena. The importance of recognizing these morphologic variants of urothelial carcinomas in the renal pelvis is to avoid confusion with other conditions. The possibility of a high-grade urothelial carcinoma should always be considered in the evaluation of a tumor displaying unusual morphologic features in the renal pelvis, and attention to proper sampling as well as the use of immunohistochemical stains will be of importance to arrive at the correct diagnosis.
